The Amplify Weight Loss Drug & Treatment ETF (THNR) offers investors a way to access international firms poised to benefit financially from advancements in weight management pharmaceuticals. Its primary objective is to mirror the investment performance (before any fees or expenses) of the VettaFi Weight Loss Drug & Treatment Index.
常見問題
Amplify Weight Loss Drug & Treatment 今天的股價是多少?▼
THNR 目前價格為 $25.90 USD,過去 24 小時上漲了 +2.07%。在圖表上更密切關注 Amplify Weight Loss Drug & Treatment 股價表現。
Amplify Weight Loss Drug & Treatment 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 ARCX 交易所,Amplify Weight Loss Drug & Treatment 的股票以代號 THNR 進行交易。
Amplify Weight Loss Drug & Treatment 的股價在上漲嗎?▼
THNR 股票較上週上漲 +4.84%,本月上漲 +4.71%,過去一年 Amplify Weight Loss Drug & Treatment 上漲 +11.14%。
Amplify Weight Loss Drug & Treatment 會發放股息嗎?▼
是的,THNR 的股息每 年度 發放一次。每股最新股息為 0.41 。截至今日,股息殖利率(FWD)% 為 1.6%。
Amplify Weight Loss Drug & Treatment 位於哪個產業?▼
Amplify Weight Loss Drug & Treatment從事於Finance & Payments產業。
Amplify Weight Loss Drug & Treatment 何時完成拆股?▼
Amplify Weight Loss Drug & Treatment 最近沒有進行任何拆股。
Amplify Weight Loss Drug & Treatment 的總部在哪裡?▼
Amplify Weight Loss Drug & Treatment 的總部位於 美國 的 Lisle。